Fresenius SE & Co. KGaA - Asset Resilience Ratio
Fresenius SE & Co. KGaA (FRE) has an Asset Resilience Ratio of 9.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Fresenius SE & Co. KGaA to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Fresenius SE & Co. KGaA's Asset Resilience Ratio has changed over time. See FRE equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Fresenius SE & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Fresenius SE & Co. KGaA worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €2.36 Billion | 5.57% |
| Short-term Investments | €1.63 Billion | 3.84% |
| Total Liquid Assets | €3.99 Billion | 9.40% |
Asset Resilience Insights
- Limited Liquidity: Fresenius SE & Co. KGaA maintains only 9.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Fresenius SE & Co. KGaA Industry Peers by Asset Resilience Ratio
Compare Fresenius SE & Co. KGaA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FRESENIUS SE+CO. ADR 1/4
F:FREA |
Medical Care Facilities | 0.40% |
|
Rede D'Or São Luiz S.A.
SA:RDOR3 |
Medical Care Facilities | 39.18% |
|
Aier Eye Hospital Group
SHE:300015 |
Medical Care Facilities | 3.43% |
|
Xian International Medical Investment Co Ltd
SHE:000516 |
Medical Care Facilities | 0.12% |
|
RHOEN-KLINIK.UNSP.ADR 1/2
F:RHKU |
Medical Care Facilities | 19.64% |
|
Medical Facilities Corporation
TO:DR |
Medical Care Facilities | 15.97% |
|
Principal Capital Public Company Limited
BK:PRINC |
Medical Care Facilities | 0.01% |
|
CareRx Corp
TO:CRRX |
Medical Care Facilities | 5.50% |
Annual Asset Resilience Ratio for Fresenius SE & Co. KGaA (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Fresenius SE & Co. KGaA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.02% | €8.00 Million ≈ $9.35 Million |
€43.55 Billion ≈ $50.91 Billion |
0.00pp |
| 2023-12-31 | 0.02% | €9.00 Million ≈ $10.52 Million |
€45.28 Billion ≈ $52.94 Billion |
-0.95pp |
| 2022-12-31 | 0.97% | €744.00 Million ≈ $869.81 Million |
€76.42 Billion ≈ $89.34 Billion |
-0.51pp |
| 2021-12-31 | 1.48% | €1.07 Billion ≈ $1.25 Billion |
€71.96 Billion ≈ $84.13 Billion |
+0.27pp |
| 2020-12-31 | 1.21% | €806.00 Million ≈ $942.30 Million |
€66.65 Billion ≈ $77.92 Billion |
+0.27pp |
| 2019-12-31 | 0.94% | €629.00 Million ≈ $735.37 Million |
€67.01 Billion ≈ $78.34 Billion |
-1.77pp |
| 2018-12-31 | 2.71% | €1.54 Billion ≈ $1.80 Billion |
€56.70 Billion ≈ $66.29 Billion |
+1.76pp |
| 2017-12-31 | 0.95% | €506.00 Million ≈ $591.57 Million |
€53.13 Billion ≈ $62.12 Billion |
+0.24pp |
| 2016-12-31 | 0.72% | €333.00 Million ≈ $389.31 Million |
€46.45 Billion ≈ $54.30 Billion |
+0.11pp |
| 2015-12-31 | 0.61% | €263.00 Million ≈ $307.47 Million |
€43.17 Billion ≈ $50.47 Billion |
+0.23pp |
| 2014-12-31 | 0.38% | €152.00 Million ≈ $177.70 Million |
€39.90 Billion ≈ $46.64 Billion |
+0.25pp |
| 2013-12-31 | 0.13% | €43.00 Million ≈ $50.27 Million |
€32.76 Billion ≈ $38.30 Billion |
-0.09pp |
| 2012-12-31 | 0.22% | €68.00 Million ≈ $79.50 Million |
€30.66 Billion ≈ $35.85 Billion |
-- |
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machin… Read more